Assisting Pulmonary Disease Diagnosis With Ophthalmic Artificial Intelligence Technology
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 10,000
- 试验地点
- 4
- 主要终点
- Area Under the Receiver Operating Characteristic curve
研究概览
简要总结
This study intends to collect ophthalmologic examination results, pulmonary examination results and related indexes from patients with pulmonary disease and control populations, and combine big data analysis and artificial intelligence technology to explore whether new methods can be provided for early screening strategies for pulmonary disease with the aid of ophthalmologic examination, and thus assist in identifying the types of pulmonary disease and determining disease prognosis.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Cross Sectional
入排标准
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Those aged ≥18 years; or those aged <18 years who can cooperate with the relevant examination and are accompanied and informed by a guardian;
- •People with respiratory-related diseases who were to undergo pulmonary examination, or those who volunteered to participate in the trial through publicity recruitment;
- •expected survival time of 3 months or more;
- •Those with no previous serious underlying disease and no history of serious eye disease;
- •Those who can cooperate with ophthalmologic and pulmonary-related examinations and have regular follow-up examinations;
- •Those who gave informed consent to the study prior to the trial and voluntarily signed the informed consent form;
- •Other conditions that can be included in the study as judged by the investigator.
排除标准
- •Patients who are unable to complete ophthalmology or pulmonary-related examinations and regular follow-ups due to serious diseases, trauma or surgery (serious ophthalmology diseases such as extremely poor vision that cannot be fixed, ocular atrophy, severe refractive interstitial clouding that prevents fundus photography, etc.);
- •People with poor compliance due to various reasons such as alcohol or drug dependence, or mental disorders;
- •Those without informed consent;
- •Other conditions judged by the investigator to be unsuitable for participation in the trial.
研究组 & 干预措施
Test group
Individuals with one or more pulmonary diseases
干预措施: Pulmonary Examination (Diagnostic Test)
Test group
Individuals with one or more pulmonary diseases
干预措施: Ophthalmic examination (Diagnostic Test)
Control group
Individuals who do not suffer from pulmonary diseases
干预措施: Ophthalmic examination (Diagnostic Test)
Control group
Individuals who do not suffer from pulmonary diseases
干预措施: Pulmonary Examination (Diagnostic Test)
结局指标
主要结局
Area Under the Receiver Operating Characteristic curve
时间窗: Through study completion, an average of 1 year
Determining the accuracy of diagnosing pulmonary disease with ophthalmic examination
次要结局
未报告次要终点